JPRN-UMIN000002218
Completed
Phase 2
A randomized trial to assess the effects of hydrogen-ride dissolution water for the patients with mild cognitive impairment (MCI). - An interventional trial for MCI using hydrogen-ride water.
Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba0 sites120 target enrollmentJuly 17, 2009
Conditionsmild cognitive impairment
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- mild cognitive impairment
- Sponsor
- Department of Neuropsychiatry, Institute of Clinical Medicine University of Tsukuba
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Meeting DSM\-IV TR criteria for dementing illnesses. 2\) Having serious or unstable illnesses. 3\) Having a history within past 5 years of serious infectious disease affecting the brain and/or malignant diseases. 4\) Having a history of alcohol or drug abuse or dependence (on DSM\-IV TR) within the past 5 years. 5\) Receiving any types of anti\-Alzheimer drugs. 6\) Recent (within 4 weeks) initiation of medications that affect the central nervous system.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
A Randomized trial to assess the effects of hydrogen-rich dissolution water for patients with impaired glucose tolerance or impaired fasting glucoseJPRN-UMIN000001329Kyoto Prefectural University of medicine60
Completed
Phase 2
A randomized trial to asses the effects of hydrogen-rich dissolution water in patients with interstitial cystitisInterstitial cystitisJPRN-UMIN000001253Koushinkai Hospital30
Recruiting
Phase 4
Oxygen therapy in severe asthmaAcute asthmaRespiratory - AsthmaACTRN12607000131459Medical Research Institute of New Zealand150
Recruiting
Phase 4
Oxygen therapy in pneumoniaPneumoniaRespiratory - Other respiratory disorders / diseasesACTRN12607000196448Medical Research Institute of New Zealand150
Completed
Not Applicable
Clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2 (COVID-19)07 COVID-19DRKS00022484Poliklinik für Zahnerhaltung und ParodontologieUniversitätsklinikum Regensburg12